Abcellera Biologics, Inc. (ABCL)
NASDAQ:ABCL
Want to see ABCL full AI Analyst Report?
AbCellera Biologics (ABCL) Ownership Overview
40.93% Insiders
4.67% Mutual Funds
19.86% Other Institutional Investors
1.36% ETFs
33.18% Public Companies and Individual Investors
The ownership structure of AbCellera Biologics (ABCL) stock is a mix of institutional, retail, and individual investors. Approximately 25.89% of the company’s stock is owned by Institutional Investors, 40.93% is owned by Insiders, and 33.18% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 18, 2026 | xxxxxxxxxxxxx | $95400 | |
Mar 02, 2026 | xxxxxxxxxxxxx | $130720 | |
Feb 27, 2026 | xxxxxxxxxxxxx | $145692 | |
Feb 27, 2026 | xxxxxxxxxxxxx | $580284 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $393780 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $105663024 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $14046479 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 56,984,009 | Insider | 18.66% | 315,121,570 | |
| 56,134,097 | Insider | 18.38% | 310,421,556 | |
| 30,275,938 | Institution | 9.91% | 167,425,937 | |
| 13,361,096 | Institution | 4.38% | 73,886,861 | |
| 9,613,674 | Insider | 3.15% | 53,163,617 | |
| 4,024,779 | Institution | 1.32% | 22,257,028 | |
| 3,051,706 | Institution | 1.00% | 16,875,934 | |
| 1,441,642 | Insider | 0.47% | 7,972,280 | |
| 727,803 | Institution | 0.24% | 4,024,751 | |
| 576,559 | Insider | 0.19% | 3,188,371 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,361,096 | Institution | 4.38% | 73,886,861 | |
| 340,523 | Institution | 0.11% | 1,883,092 | |
| 249,240 | Institution | 0.08% | 1,378,297 | |
| 176,961 | Institution | 0.06% | 978,594 | |
| 58,472 | Institution | 0.02% | 323,350 | |
| 44,214 | Institution | 0.01% | 244,503 | |
| 29,481 | Institution | <0.01% | 163,030 | |
| 9,145 | Institution | <0.01% | 50,572 | |
| 3 | Institution | 0.00% | 17 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,701,684 | Institution | 0.56% | 9,410,313 | |
| 564,320 | Institution | 0.18% | 3,069,901 | |
| 414,577 | Institution | 0.14% | 2,292,611 | |
| 232,702 | Institution | 0.08% | 1,286,842 | |
| 163,483 | Institution | 0.05% | 889,348 | |
| 135,588 | Institution | 0.04% | 749,802 | |
| 64,811 | Institution | 0.02% | 352,572 | |
| 59,315 | Institution | 0.02% | 328,012 | |
| 40,849 | Institution | 0.01% | 225,895 | |
| 39,804 | Institution | 0.01% | 216,534 |
FAQ
Who Owns Abcellera Biologics, Inc. (ABCL)?
According to the latest TipRanks data, approximately 19.86% of the company's stock is held by institutional investors, 40.93% is held by insiders, and 33.18% is held by retail investors.
What percentage of Abcellera Biologics, Inc. (ABCL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.86% of Abcellera Biologics, Inc. (ABCL) stock is held by institutional investors.
What percentage of Abcellera Biologics, Inc. (ABCL) stock is held by retail investors?
According to the latest TipRanks data, approximately 33.18% of Abcellera Biologics, Inc. (ABCL) stock is held by retail investors.
Who owns the most shares of Abcellera Biologics, Inc. (ABCL)?
Carl L. G. Hansen owns the most shares of Abcellera Biologics, Inc. (ABCL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.